{
    "id": "NCLEX_MatrixMatch_001",
    "caseId": "CirrhosisCase_001",
    "questionType": "matrixMatch",
    "question": "The nurse is caring for a 62-year-old client with decompensated cirrhosis and severe ascites. The nurse reviews the client's electronic health record to evaluate the effectiveness of interventions implemented over the past 24 hours. For each intervention listed, click to specify if the intervention was effective, ineffective, or contraindicated/requires further action based on the provided client data.",
    "context": {
        "tabs": [
            {
                "title": "Nurses' Notes",
                "content": "24 hours ago: Client admitted with grade 3 ascites, shortness of breath, and confusion. Abdomen is tense and distended. Asterixis present. Oriented to person only. Interventions initiated per provider's orders.\n\nToday (0800): Client is alert and oriented to person, place, and time. Reports feeling less 'bloated'. No asterixis noted. Respirations are unlabored at 18/min."
            },
            {
                "title": "Vital Signs & Measurements",
                "content": "| | 24 Hours Ago | Today (0800) |\n|---|---|---|\n| **Weight** | 90 kg (198 lbs) | 86 kg (189.2 lbs) |\n| **Abdominal Girth** | 115 cm | 108 cm |\n| **Blood Pressure**| 105/68 mmHg | 98/60 mmHg |\n| **Heart Rate** | 98/min | 88/min |"
            },
            {
                "title": "Laboratory Results",
                "content": "| | 24 Hours Ago | Today (0800) |\n|---|---|---|\n| **Sodium** | 130 mEq/L | 124 mEq/L |\n| **Potassium** | 3.6 mEq/L | 5.8 mEq/L |\n| **BUN** | 25 mg/dL | 35 mg/dL |\n| **Creatinine** | 1.3 mg/dL | 2.5 mg/dL |\n| **Ammonia** | 95 mcg/dL | 40 mcg/dL |"
            },
            {
                "title": "Medication Administration Record",
                "content": "- Paracentesis (4 liters removed) - completed 18 hours ago\n- Lactulose 30 mL orally three times daily\n- Spironolactone 100 mg orally daily\n- Furosemide 40 mg IV twice daily\n- 2-gram sodium diet"
            }
        ]
    },
    "rows": [
        {
            "id": "row_0",
            "label": "Lactulose 30 mL orally TID"
        },
        {
            "id": "row_1",
            "label": "Spironolactone 100 mg orally daily"
        },
        {
            "id": "row_2",
            "label": "Paracentesis (4L removed)"
        },
        {
            "id": "row_3",
            "label": "Furosemide 40 mg IV BID"
        },
        {
            "id": "row_4",
            "label": "2-gram sodium diet"
        }
    ],
    "columns": [
        {
            "id": "col_0",
            "label": "Effective"
        },
        {
            "id": "col_1",
            "label": "Ineffective"
        },
        {
            "id": "col_2",
            "label": "Contraindicated/Requires Further Action"
        }
    ],
    "answers": [
        {
            "rowId": "row_0",
            "columnId": "col_0"
        },
        {
            "rowId": "row_1",
            "columnId": "col_2"
        },
        {
            "rowId": "row_2",
            "columnId": "col_0"
        },
        {
            "rowId": "row_3",
            "columnId": "col_2"
        },
        {
            "rowId": "row_4",
            "columnId": "col_2"
        }
    ],
    "rationale": {
        "correct": "The nurse correctly evaluates the client's response to treatment by integrating physical assessment findings and laboratory results. Lactulose was effective, as evidenced by improved mental status and decreased ammonia levels. Paracentesis was effective, as shown by reduced weight and abdominal girth. However, spironolactone, furosemide, and the sodium-restricted diet require further action. Spironolactone led to life-threatening hyperkalemia. Furosemide contributed to acute kidney injury (elevated BUN/creatinine), a sign of hepatorenal syndrome. The sodium restriction, in the context of diuretic use, has resulted in significant hyponatremia, which requires re-evaluation of fluid and sodium management.",
        "incorrect": "An incorrect evaluation would fail to recognize the adverse effects of the diuretic therapy and diet. For example, classifying spironolactone as effective ignores the critical hyperkalemia. Classifying furosemide as effective ignores the worsening renal function. Classifying the 2-gram sodium diet as effective overlooks the severe hyponatremia, a dangerous electrolyte imbalance. Correctly evaluating outcomes requires a comprehensive analysis of all data, not just the desired effects.",
        "answerBreakdown": [
            {
                "rowId": "row_0",
                "columnId": "col_0",
                "label": "Lactulose 30 mL orally TID",
                "content": "This intervention is **Effective**. The goal of lactulose in cirrhosis is to treat hepatic encephalopathy by reducing serum ammonia levels. The client's ammonia level decreased from 95 to 40 mcg/dL, their confusion resolved (oriented x3), and asterixis is no longer present. These are the desired therapeutic outcomes.",
                "isCorrect": true
            },
            {
                "rowId": "row_1",
                "columnId": "col_2",
                "label": "Spironolactone 100 mg orally daily",
                "content": "This intervention is **Contraindicated/Requires Further Action**. Spironolactone is a potassium-sparing diuretic. The client's potassium level has risen to a critical level of 5.8 mEq/L (normal 3.5-5.0 mEq/L). Hyperkalemia can cause life-threatening cardiac dysrhythmias. The nurse must hold this medication and notify the provider immediately.",
                "isCorrect": true
            },
            {
                "rowId": "row_2",
                "columnId": "col_0",
                "label": "Paracentesis (4L removed)",
                "content": "This intervention is **Effective**. The large-volume paracentesis successfully removed ascitic fluid, as evidenced by a 4 kg weight loss and a 7 cm reduction in abdominal girth. This also addressed the client's initial shortness of breath, as noted by the now unlabored respirations.",
                "isCorrect": true
            },
            {
                "rowId": "row_3",
                "columnId": "col_2",
                "label": "Furosemide 40 mg IV BID",
                "content": "This intervention is **Contraindicated/Requires Further Action**. The client's creatinine has doubled from 1.3 to 2.5 mg/dL, and BUN has increased, indicating significant acute kidney injury. In clients with cirrhosis, aggressive diuresis with loop diuretics like furosemide can precipitate hepatorenal syndrome. This finding requires holding the medication and notifying the provider.",
                "isCorrect": true
            },
            {
                "rowId": "row_4",
                "columnId": "col_2",
                "label": "2-gram sodium diet",
                "content": "This intervention **Requires Further Action**. While sodium restriction is a cornerstone of ascites management, the client has developed significant hyponatremia (124 mEq/L). This dilutional hyponatremia is common in advanced cirrhosis and can be exacerbated by diuretics. This severe electrolyte imbalance requires provider notification and a potential change in the plan, such as initiating a fluid restriction.",
                "isCorrect": true
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Evaluate",
        "cjmmStep": "Evaluate Outcomes",
        "nclexCategory": "Physiological Adaptation",
        "difficulty": 4,
        "topicTags": [
            "Cirrhosis",
            "Ascites",
            "Hepatic Encephalopathy",
            "Electrolyte Imbalance",
            "Pharmacology",
            "Fluid and Electrolytes"
        ]
    }
}